Organogenesis Holdings Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
/ 
Frequently asked questions
To buy Organogenesis Holdings Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Organogenesis Holdings Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Organogenesis Holdings Inc. is ORGO:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Organogenesis Holdings Inc. has its primary listing on NASDAQ (Small cap). You can trade Organogenesis Holdings Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Organogenesis Holdings Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Organogenesis Holdings Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Organogenesis Holdings Inc..